Aclaris Therapeutics(ACRS) - 2024 Q3 - Quarterly Report
Aclaris Therapeutics(ACRS)2024-11-07 05:30
Table of Contents 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 to | --- | |----------------------------------------------------------------------------------------------| | For the transition period from | | Commission File Numb ...